PMHNP Scope of Practice for Anxiety in Georgia

If you’re a psychiatrist or PMHNP treating anxiety disorders via telehealth, you’re navigating a regulatory landscape that’s constantly shifting. Between federal DEA rules on controlled substances, state-specific prescribing laws, and the evolving scope of practice for nurse practitioners, staying compliant isn’t optional — it’s the price of admission.

Here’s the reality: treating anxiety remotely is legally complex, but understanding the rules protects both your practice and your patients. Whether you’re prescribing SSRIs for generalized anxiety or managing benzodiazepines for panic disorder, the regulations governing your practice depend on where your patient sits, what credentials you hold, and which medications you’re prescribing.

Let’s break down what you actually need to know.

The Federal Baseline: DEA Rules on Telehealth Prescribing

The Ryan Haight Act normally requires an in-person medical evaluation before prescribing any controlled substance ‘by means of the Internet.’ For anxiety providers, this matters because many acute anxiety medications — particularly benzodiazepines like alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin) — are Schedule IV controlled substances.

Here’s where it gets interesting: Since March 2020, federal authorities have waived this requirement under COVID-19 public health emergency provisions. As of December 31, 2025, the DEA extended these telehealth flexibilities for the third time, meaning you can still prescribe controlled anxiety medications after a telehealth-only evaluation — no in-person visit required.

But this is temporary. The DEA proposed rules in 2023 that would have reinstated in-person requirements (with limited exceptions), triggering over 38,000 public comments from providers and patients. The agency backed off and is now working on a ‘new path forward for telemedicine.’ Translation: Expect potential changes in 2026 or beyond.

What This Means for Your Practice

Right now, you can:

• Conduct a video evaluation with a new anxiety patient
• Prescribe benzodiazepines, SSRIs, SNRIs, or other psychiatric medications
• Continue treatment entirely via telehealth

You must still:

• Hold a valid DEA registration in your state of practice
• Document the telehealth encounter thoroughly
• Follow state prescription drug monitoring program (PDMP) requirements
• Ensure prescriptions are issued for legitimate medical purposes within the usual course of professional practice

The compliance uncertainty is real. Many providers are preparing for potential hybrid models — maintaining relationships with affiliate clinics for in-person exams if requirements return, or planning to use DEA’s proposed ‘special telemedicine registration’ if it’s ever implemented.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists: Full Authority, Full Responsibility

As a licensed psychiatrist (MD/DO), your scope of practice for anxiety treatment is the broadest in behavioral health. Every state authorizes you to independently:

• Diagnose any anxiety disorder
• Prescribe any FDA-approved medication, including Schedule II-V controlled substances
• Provide psychotherapy or medication management (or both)
• Practice without supervision or collaborative agreements

The Catch: Licensing and Compliance

Geography matters. You must hold a valid medical license in every state where your patients are located. Treating a California patient from your New York office without a California license? That’s practicing medicine without a license — a serious violation.

Multi-state licensing options:

• Interstate Medical Licensure Compact (IMLC): Streamlines licensure across 40+ member states including Texas, Illinois, Pennsylvania, and Florida
• Notable exceptions: California and New York are NOT in the IMLC — you’ll need to go through their full licensing processes

Prescribing Compliance Essentials

State PDMP requirements are non-negotiable. Examples:

New York: Must check the I-STOP PMP registry before every Schedule II-IV prescription (including all benzodiazepines). No exceptions for established patients.

Florida: Required PDMP check before prescribing any Schedule II-V controlled substance, then at least every 90 days for ongoing therapy.

Texas: Mandatory PDMP consultation for opioids, benzodiazepines, barbiturates, and carisoprodol before prescribing.

Pennsylvania: Must check PA PDMP before the initial prescription of any benzodiazepine or opioid AND for each subsequent refill.

Nearly all states also require or strongly encourage electronic prescribing. California and New York mandate e-prescriptions for all medications (controlled or not). Your telehealth platform should provide DEA-compliant EPCS (Electronic Prescribing for Controlled Substances) with two-factor authentication.

PMHNPs: Capability Meets State-Specific Constraints

Psychiatric Mental Health Nurse Practitioners are fully trained to diagnose and treat anxiety disorders, but your prescribing authority varies significantly by state. The differences center on two questions:

1. Can you practice independently or do you need physician oversight?
2. What controlled substances can you prescribe?

Independent vs. Collaborative Practice

Full Practice Authority States (for experienced NPs):

• Illinois: After 4,000 hours of clinical experience, you can practice independently, including prescribing (with a physician consult relationship required only for Schedule II narcotics during your first 5 years of full practice authority)
• New York: After 3,600 hours under physician collaboration, you gain full practice authority — no supervising physician needed
• California: Transitioning to independence by January 2026 for experienced NPs who meet certification criteria (currently restricted to certain practice settings)

Restricted Practice States:

• Texas: Must have a Prescriptive Authority Agreement (PAA) with a collaborating physician
• Florida: Requires a supervisory protocol with a physician (psychiatric NPs are NOT included in Florida’s autonomous NP exemptions)
• Pennsylvania: Collaborative agreement with a physician mandatory; one physician can supervise up to 4 NPs

Controlled Substance Prescribing: The Fine Print

Schedule IV benzodiazepines (the most common anxiety medications) are generally within NP scope across all states — but with conditions:

Texas: You cannot prescribe Schedule II controlled substances in outpatient settings except in hospitals or hospice care. For anxiety treatment, this mainly affects comorbid ADHD patients (stimulants are Schedule II). Benzodiazepines (Schedule IV) are permitted under your prescriptive authority agreement.

Florida: NPs can prescribe Schedule II for only a 7-day supply unless you’re a certified psychiatric nurse treating mental illness — in which case the 7-day limit doesn’t apply to psychiatric medications. This carve-out recognizes the specialty nature of PMHNP practice.

Pennsylvania: You can prescribe Schedule II for up to 30 days and Schedule III-IV for up to 90 days, consistent with your collaborative agreement. The collaborating physician must be notified of Schedule II prescriptions within 24 hours.

California: Under standardized procedures (currently required), you can prescribe controlled substances with physician protocol approval. By 2026, qualified independent NPs will prescribe under their own authority.

Illinois: With full practice authority, you can prescribe Schedule II-V independently, though physician consultation is required for Schedule II narcotics during your first 5 years of FPA. For benzodiazepines and other Schedule III-IV drugs, no physician input is required by law.

State-by-State Telehealth Prescribing Rules

California

• No in-person exam required by state law if standard of care is met via telehealth
• Telehealth examination (even asynchronous components) acceptable for prescribing
• CURES PDMP check mandatory for Schedule II-IV drugs at least every 4 months
• E-prescribing required for all prescriptions
• Not in IMLC; full CA license required for out-of-state providers

Texas

• Real-time audio-visual exam required to establish patient relationship
• Telehealth prescribing of controlled substances permitted except for chronic pain management (Schedule II for chronic pain via telemedicine is prohibited — doesn’t affect anxiety treatment)
• TX PMP check mandatory for benzos, opioids, barbiturates, and carisoprodol before prescribing
• IMLC member state (easier multi-state licensing for physicians)

Florida

• Explicit telehealth statute with unique controlled substance rules
• Schedule II prescribing via telehealth is banned EXCEPT for psychiatric treatment, inpatient care, hospice, or nursing home settings — so psychiatrists and PMHNPs CAN prescribe stimulants or other Schedule IIs for mental health conditions remotely
• Out-of-state telehealth registration available (you can register to practice in FL without full licensure if you meet eligibility requirements)
• E-FORCSE PDMP check required before prescribing any Schedule II-V controlled substance and every 90 days for ongoing therapy
• Written patient consent for telehealth treatment required

New York

• No in-person exam mandate — telehealth evaluation sufficient if it meets standard of care
• I-STOP PDMP consultation mandatory before every Schedule II-IV prescription (includes all benzos)
• E-prescribing required for all medications since 2016
• Not in IMLC; full NY license required
• Experienced NPs (3,600+ hours) can practice independently as of 2022

Pennsylvania

• No statutory telehealth prescribing restrictions — follows federal DEA rules
• Real-time interactive audio-video recommended for initial evaluations
• PA PDMP check required before initial benzodiazepine or opioid prescription AND for each subsequent refill
• E-prescribing mandatory for controlled substances since 2019
• IMLC member state
• NPs still require collaborative agreements (independence bills proposed but not yet enacted)

Illinois

• Audio-only telehealth explicitly permitted for mental health services when video isn’t available
• No state requirement for in-person exam
• Illinois PMP check required for Schedule II prescriptions; strongly encouraged for all controlled substances
• Separate state controlled substance license required (in addition to DEA registration)
• IMLC member for physicians; joined Nurse Licensure Compact for RNs in 2022
• Full practice authority available for experienced NPs (4,000+ hours)

Comparison Table: Key State Requirements for Anxiety Prescribers

FAQs: What Anxiety Prescribers Actually Ask

Can I prescribe benzodiazepines after a video visit with a new patient?
Yes, under current federal waivers (through December 31, 2025). You must conduct an appropriate telehealth evaluation, document it thoroughly, check your state’s PDMP as required, and ensure prescribing meets standard of care. These waivers may change in 2026.

Do I need an in-person visit before prescribing controlled anxiety medications?
Not currently, thanks to COVID-era DEA flexibilities extended through 2025. However, individual states may have additional requirements. Most states in our analysis don’t mandate in-person exams for psychiatric telehealth, but always verify your specific state’s rules.

What’s the difference between psychiatrist and PMHNP prescribing authority for anxiety?
Psychiatrists have full independent prescribing authority in all states for any medication. PMHNPs’ authority varies: some states grant full independence after meeting experience requirements, while others require physician collaboration. Certain states (like Texas) restrict NP prescribing of Schedule II drugs in outpatient settings.

Can I treat patients in multiple states via telehealth?
Yes, but you must hold a valid license in each state where patients are located. The Interstate Medical Licensure Compact (IMLC) simplifies this for physicians in 40+ states. California and New York are NOT in the IMLC and require separate full licenses. Some states (like Florida) offer special telehealth registrations for out-of-state providers.

What happens if DEA changes the telehealth prescribing rules?
The DEA is working on permanent telemedicine regulations for controlled substances. Proposed 2023 rules would have required in-person exams (with limited 30-day telehealth allowances), but after significant pushback, DEA extended current flexibilities while developing new guidance. Stay informed through your state medical/nursing board and consider contingency plans like hybrid care models.

Are PDMP checks required for SSRIs and other non-controlled anxiety medications?
No. PDMP requirements apply only to controlled substances (typically Schedule II-V). However, checking your state’s PDMP for new patients can provide valuable clinical information about overall medication use, even when prescribing non-controlled medications.

The Bottom Line: Compliance Protects Your Practice

Treating anxiety via telehealth offers enormous benefits — better access for patients, flexible scheduling, and the ability to serve underserved areas. But the regulatory complexity is real.

Key takeaways:

• Federal DEA waivers currently allow controlled substance prescribing via telehealth through 12/31/2025, but changes are likely coming
• Psychiatrists have full prescribing authority but must navigate state licensing and PDMP requirements
• PMHNP authority varies significantly by state — from full independence to required physician oversight
• Every state has unique telehealth and prescribing regulations; multi-state practice requires careful compliance tracking
• PDMP checks, e-prescribing, and thorough documentation are non-negotiable

The regulatory landscape rewards providers who stay informed and build compliance into their workflow from day one. Platforms like Klarity Health handle much of this infrastructure — ensuring you’re licensed in the states where you practice, integrating PDMP checks, providing compliant e-prescribing systems, and updating protocols when regulations change.

Rather than building your own patient acquisition engine and navigating 50 different state regulatory frameworks alone, consider a model where qualified patients are matched to you, compliance is built-in, and you’re paid only when you see patients. That’s the economic and regulatory reality of sustainable telehealth practice in 2025.

Sources

1. DEA & HHS, ‘DEA and HHS Extend Telemedicine Flexibilities through 2025,’ November 15, 2024, https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. Center for Connected Health Policy, ‘State Telehealth Policies for Online Prescribing,’ Updated January 9, 2026, https://www.cchpca.org/topic/online-prescribing/

3. Florida Statutes §456.47 (Telehealth Services) and §464.012 (APRN Controlled Substance Prescribing), 2025 Edition, http://www.leg.state.fl.us/Statutes/

4. New York Department of Health, ‘I-STOP Prescription Monitoring Program,’ Effective August 27, 2013 (accessed 2025), https://health.ny.gov/professionals/narcotic/prescription_monitoring

5. Rivkin Radler LLP, ‘New Law Allows Experienced NPs to Practice Independently in NY,’ April 13, 2022, https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/

Source:

• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=forward%20for%20telemedicine%2C%20DEA%20and,through%20the%20end%20of%202024
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Controlled%20Substance%20Act
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Note%20that%20the%20practice%20of,chapter%205%20of%20title%205
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,services%20within%20the%20applicable%20scope
• https://healthweb-back.health.ny.gov/professionals/narcotic/prescription_monitoring/#:~:text=Effective%20August%2027%2C%202013%2C%20most,to%20view%20dispensed%20controlled%20substance
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=may%20prescribe%20Schedule%20II%20drugs%3F,care%20from%20a%20qualified%20hospice
• https://www.leg.state.fl.us/Statutes/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=893.03%20to%20a%207,formulary%20which%20it%20finds%20is
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Additionally%2C%20the%20rule%20shall%20state,addiction%20medicine%2C%20or%20palliative%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=The%20Attorney%20General%20may%20issue,application%20for%20such%20special%20registration%E2%80%94